What is the appropriate workup for suspected syndrome of inappropriate antidiuretic hormone secretion (SIADH)?

Workup for SIADH

When SIADH is suspected, the diagnostic workup centers on confirming hypotonic hyponatremia with inappropriately concentrated urine and elevated urinary sodium in a euvolemic patient, while systematically excluding other causes of hyponatremia through targeted laboratory testing and clinical assessment.

Essential Diagnostic Criteria

The diagnosis of SIADH requires five cardinal features to be present simultaneously 1, 2:

• Hypotonic hyponatremia: Serum sodium <135 mmol/L (pursue full workup when <131 mmol/L) with serum osmolality <275 mOsm/kg 1, 3, 2
• Inappropriately concentrated urine: Urine osmolality >100 mOsm/kg (typically >300–500 mOsm/kg) relative to low plasma osmolality 1, 4, 5, 2
• Elevated urinary sodium: Urine sodium concentration >20–40 mEq/L (often >30 mEq/L) with normal salt intake 1, 4, 5, 2
• Clinical euvolemia: Absence of edema, orthostatic hypotension, dry mucous membranes, or signs of volume depletion 1, 2
• Normal renal, thyroid, and adrenal function: Confirmed through exclusion testing 1, 2

Core Laboratory Panel

Initial Blood Tests

• Serum sodium and osmolality: Confirms hyponatremia and hypoosmolality; calculate plasma osmolality using: 2 × Na (mEq/L) + BUN (mg/dL)/2.8 + glucose (mg/dL)/18 (normal 275–295 mOsm/kg) 1
• Serum creatinine and BUN: Assess renal function and exclude renal causes of hyponatremia 1
• Serum uric acid: Level <4 mg/dL has 73–100% positive predictive value for SIADH 1, 5
• Serum glucose: Exclude hyperglycemia-induced pseudohyponatremia (add 1.6 mEq/L to sodium for each 100 mg/dL glucose >100 mg/dL) 1

Urine Studies

A spot (random) urine sample is sufficient and equivalent to 24-hour collection for diagnostic purposes 6, 5:

• Urine osmolality: Should be inappropriately elevated (>100 mOsm/kg, typically >300–500 mOsm/kg) despite low serum osmolality 1, 4, 6, 2
• Urine sodium concentration: Typically >20–40 mEq/L; spot urine values correlate well with 24-hour collections 1, 6, 5
• Fractional excretion of sodium (FENa) and urea (FEurea): In patients with severely reduced urine output, FENa >0.15% and FEurea >45% reliably distinguish SIADH from true salt-depletion states 1

Mandatory Exclusion Tests

Thyroid Function

• TSH level: Rule out hypothyroidism, which can mimic SIADH 1, 4
• Normal thyroid function is expected in true SIADH 4

Adrenal Function

• Morning cortisol level or ACTH stimulation test: Exclude adrenal insufficiency 1
• Cortisol >18–20 µg/dL in acute illness makes adrenal insufficiency unlikely 1
• Normal adrenal function is a prerequisite for SIADH diagnosis 1, 2

Volume Status Assessment

Physical examination alone is unreliable (sensitivity 41%, specificity 80%) and must be supplemented with clinical context 1:

Signs of Euvolemia (SIADH)

• No edema, no orthostatic hypotension, normal skin turgor, moist mucous membranes 1, 3
• Central venous pressure (CVP) 6–10 cm H₂O if measured 1, 3

Distinguishing from Cerebral Salt Wasting (Critical in Neurosurgical Patients)

• CSW characteristics: True hypovolemia with orthostatic hypotension, tachycardia, dry mucous membranes, flat neck veins, CVP <6 cm H₂O, urine sodium >20 mEq/L despite volume depletion 1, 3
• SIADH characteristics: Euvolemic state, CVP 6–10 cm H₂O, no signs of volume depletion 1, 3
• This distinction is critical because treatments are opposite: SIADH requires fluid restriction while CSW requires volume and sodium replacement 1, 4, 3

Tests NOT Recommended

• Plasma ADH/vasopressin levels: Not supported by evidence, delays diagnosis, and does not alter management 1
• Natriuretic peptide levels: Adds no clinical value to diagnosis 1

Underlying Cause Investigation

Medication Review

Systematically review all medications, particularly 4, 7:

• Antidepressants: SSRIs, SNRIs
• Antiepileptics: Carbamazepine, oxcarbazepine
• Chemotherapy: Cisplatin, vinca alkaloids (vincristine, vinblastine), cyclophosphamide
• Analgesics: NSAIDs, opioids, tramadol
• Other: Desmopressin, certain antipsychotics

Imaging and Additional Workup

• Chest X-ray: Identify pulmonary causes of SIADH (pneumonia, tuberculosis, malignancy) 1
• CT chest/abdomen: Consider if malignancy suspected, particularly small cell lung cancer (SIADH affects 1–5% of lung cancer patients) 1
• Brain imaging (CT/MRI): If CNS pathology suspected (stroke, hemorrhage, infection, tumor) 1, 2

Diagnostic Algorithm Summary

1. Confirm hyponatremia: Serum sodium <135 mmol/L with serum osmolality <275 mOsm/kg 1
2. Obtain spot urine: Measure osmolality (should be >100 mOsm/kg) and sodium (should be >20–40 mEq/L) 1, 6
3. Assess volume status: Clinical examination supplemented by CVP if available; confirm euvolemia 1, 3
4. Exclude alternative diagnoses: TSH, morning cortisol, serum creatinine/BUN 1
5. Check serum uric acid: <4 mg/dL supports SIADH diagnosis 1, 5
6. Review medications: Identify and discontinue offending agents if possible 4, 7
7. Investigate underlying cause: Chest imaging, brain imaging, malignancy workup as indicated 1, 2

Common Diagnostic Pitfalls

• Failing to obtain urine osmolality and sodium before initiating therapy can lead to misdiagnosis 1
• Relying solely on physical examination for volume assessment without laboratory correlation may misclassify patients 1
• Not reviewing medications that can induce SIADH may miss a reversible cause 1, 4
• Omitting thyroid and adrenal function tests before confirming SIADH can result in incorrect diagnosis 1
• Misdiagnosing CSW as SIADH in neurosurgical patients leads to inappropriate fluid restriction and worsens outcomes 1, 4, 3